Creative Biolabs is one of the well-recognized experts who are professional in applying advanced technologies and extensive experience for a broad range of antibacterial drug discovery services. Our service can be tailored to meet the customer’s project and assay-specific requirements.
During the past decades, the clinical introduction of antibiotics has been served as the most success against bacterial infections. However, the rise of multidrug resistance in bacteria rendering pathogens unresponsive to many existing drugs has been a critical global healthcare issue. The World Health Organization has published the global priority list of severe bacterial pathogens to guide novel antibiotics research, discovery, and development. In this case, there is a highly urgent need for developing novel antibiotics against severe bacterial pathogens, especially drug-resistant bacterial. Now Creative Biolabs has built the one-stop antibacterial drug discovery platform against severe bacterial pathogens. From the target identification to the final IND-Enabling, our complete procedure has the capability to enable you to free up your time for core work and project. Besides, we also provide the antimicrobial peptide discovery service as antimicrobial peptides (AMPs) have been considered an effective source for novel therapies. The macromolecular synthesis assay and bacterial cytological profiling (BCP) are also rapid and powerful approaches to identify the cellular pathway affected by antibacterial molecules.
Severe Bacterial Pathogens
To fill the gaps of antibacterial drug discovery against antibiotic resistant pathogens, Creative Biolabs offers academic and industrial researches depending on novel research methods and tools. We are capable of meeting the specific need of each customer with the best project design. If you are interested in our services, please do not hesitate to contact us for more details.
For Research Use Only.
